Cargando…
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors
SIMPLE SUMMARY: The aim of this study was to present and analyze the up-to-date literature describing the epidemiology, genetics, and histopathology of bladder cancer, as well as the latest methods of bladder cancer treatment. The treatment of urothelial cancer was divided depending on its stage and...
Autores principales: | Szklener, Katarzyna, Chmiel, Paulina, Michalski, Adam, Mańdziuk, Sławomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946699/ https://www.ncbi.nlm.nih.gov/pubmed/35326568 http://dx.doi.org/10.3390/cancers14061416 |
Ejemplares similares
-
Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
New Directions in the Therapy of Glioblastoma
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023) -
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors
por: Casadei, Chiara, et al.
Publicado: (2019)